Inhibikase Therapeutics shares owned by State Street Corporation
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by State Street Corporation
from 13F filings
Historical chart of State Street Corporation investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by State Street Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by State Street Corporation
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $823k | 508k | 1.62 |
| 2025-06-30 | $776k | 398k | 1.95 |
| 2025-03-31 | $92k | 42k | 2.19 |
| 2024-12-31 | $136k | 42k | 3.25 |
| 2024-09-30 | $13k | 10k | 1.30 |
| 2024-06-30 | $13k | 10k | 1.31 |
| 2024-03-31 | $22k | 10k | 2.16 |
| 2023-12-31 | $13k | 10k | 1.27 |
| 2023-09-30 | $14k | 10k | 1.41 |
| 2023-06-30 | $35k | 10k | 3.48 |